These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9987798)
21. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Holland EJ; Bartlett JD; Paterno MR; Usner DW; Comstock TL Cornea; 2008 Jan; 27(1):50-5. PubMed ID: 18245967 [TBL] [Abstract][Full Text] [Related]
22. Possibilities in improvement of glucocorticoid treatments in asthma with special reference to loteprednol etabonate. Szelenyi I; Hermann R; Petzold U; Pahl A; Hochhaus G Pharmazie; 2004 May; 59(5):409-11. PubMed ID: 15212311 [TBL] [Abstract][Full Text] [Related]
23. Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits. Novaes GS; Mello SB; Laurindo IM; Cossermelli W J Rheumatol; 1996 Dec; 23(12):2092-7. PubMed ID: 8970046 [TBL] [Abstract][Full Text] [Related]
24. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Amon M; Busin M Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339 [TBL] [Abstract][Full Text] [Related]
26. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
27. [Effect of cyclophosphamide (Endoxan) on experimental arthritis in rabbits]. Chlud K Z Rheumatol; 1978; 37(5-6):174-69. PubMed ID: 685513 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis. Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491 [TBL] [Abstract][Full Text] [Related]
29. [Anti-inflammatory effect of THS-201, a new intra-articular steroid]. Kiniwa M; Yamamoto N; Hashimoto Y; Miyake H; Masuda H Nihon Yakurigaku Zasshi; 1986 Jan; 87(1):89-97. PubMed ID: 3957156 [TBL] [Abstract][Full Text] [Related]
30. Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. Fischetti F; Durigutto P; Macor P; Marzari R; Carretta R; Tedesco F Arthritis Rheum; 2007 Apr; 56(4):1187-97. PubMed ID: 17393439 [TBL] [Abstract][Full Text] [Related]
31. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Lippross S; Moeller B; Haas H; Tohidnezhad M; Steubesand N; Wruck CJ; Kurz B; Seekamp A; Pufe T; Varoga D Arthritis Rheum; 2011 Nov; 63(11):3344-53. PubMed ID: 21769848 [TBL] [Abstract][Full Text] [Related]
32. Arthritis in the rabbit knee joint: a quantitated model. DeShazo CV; DeShazo MM Rheumatology; 1975; 6():268-82. PubMed ID: 128110 [TBL] [Abstract][Full Text] [Related]
33. Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Druzgala P; Wu WM; Bodor N Curr Eye Res; 1991 Oct; 10(10):933-7. PubMed ID: 1959381 [TBL] [Abstract][Full Text] [Related]
34. Microbubble-enhanced ultrasound exposure promotes uptake of methotrexate into synovial cells and enhanced antiinflammatory effects in the knees of rabbits with antigen-induced arthritis. Nakaya H; Shimizu T; Isobe K; Tensho K; Okabe T; Nakamura Y; Nawata M; Yoshikawa H; Takaoka K; Wakitani S Arthritis Rheum; 2005 Aug; 52(8):2559-66. PubMed ID: 16059891 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. Hochhaus G; Chen LS; Ratka A; Druzgala P; Howes J; Bodor N; Derendorf H J Pharm Sci; 1992 Dec; 81(12):1210-5. PubMed ID: 1491342 [TBL] [Abstract][Full Text] [Related]
36. [Arthrocentesis in rheumatology practice]. Hartmann H Tidsskr Nor Laegeforen; 2000 Mar; 120(7):800-2. PubMed ID: 10806902 [TBL] [Abstract][Full Text] [Related]
37. Loteprednol etabonate: clinical potential in the management of ocular inflammation. Noble S; Goa KL BioDrugs; 1998 Oct; 10(4):329-39. PubMed ID: 18020605 [TBL] [Abstract][Full Text] [Related]
38. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. van de Loo AA; Arntz OJ; Bakker AC; van Lent PL; Jacobs MJ; van den Berg WB Am J Pathol; 1995 Jan; 146(1):239-49. PubMed ID: 7856731 [TBL] [Abstract][Full Text] [Related]
39. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229 [TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Macor P; Durigutto P; De Maso L; Garrovo C; Biffi S; Cortini A; Fischetti F; Sblattero D; Pitzalis C; Marzari R; Tedesco F Arthritis Rheum; 2012 Aug; 64(8):2559-67. PubMed ID: 22334275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]